World of DTC Marketing
AUGUST 29, 2022
DTC marketers spend a lot of time and money gaining insights into patients and caregivers. That information should be shared with HCPs and insurers to understand better the barriers and opportunities of treating patients. A sales representative for a biotech company shared information with oncologists about patients’ attitudes towards treatment options, including the company’s brand.
MedCity News
AUGUST 29, 2022
Rural health systems should be the champions of virtual care delivery, according to Jim Weinstein, Microsoft’s senior vice president of health equity and innovation. He and Sheri Dodd, vice president and general manager of Medtronic Care Management Services, laid out recommendations for rural providers to establish scalable and sustainable virtual care programs during a conference held last week by Sanford Health.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
AUGUST 29, 2022
In the pharmaceutical business, as with any other business, you can’t market what you haven’t brought to market. It’s no secret that few (if any) other industries face the scientific, economic, and regulatory hurdles in bringing products to the people as this one does. The hurdles are there for good reason, of course. The U.S. Food and Drug Administration (FDA) and their international peers protect us all from ineffective, substandard, and even dangerous compounds, whether produced willfully by
MedCity News
AUGUST 29, 2022
Community pharmacies need to ramp up now to be ready for 2023 and ensure their operations, technology and partnerships are in tip-top shape should more unexpected economic turbulence arrive.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
PharmaVoice
AUGUST 29, 2022
A collaboration between Stanford University researchers and Komodo Health aims to advance knowledge of lingering COVID symptoms, health disparities and intervention strategies.
MedCity News
AUGUST 29, 2022
If Medicare expanded coverage of SUD treatment, it would incur an additional $1.9 billion annually, the report estimated. However, this would be offset by about $1.6 billion in savings.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
AUGUST 29, 2022
Where home care can really shine is within value-based care arrangements. Finding out someone has hypertension early can lead to medication that reduces the likelihood of heart failure, and paying for an in-home checkup is well worth the expense for the overall savings it can confer to whoever has payment responsibility. .
PM360
AUGUST 29, 2022
Members of Generation Z are emerging into adulthood and quickly becoming one of the most discerning, thoughtful cohorts of consumers in U.S. history. As they grow more financially independent, they will begin to use their large collective spending power to choose healthcare options that fit their lifestyle, ethics, and personal brand. In a previous post , I talked about how to tailor healthcare messaging to this technologically minded, brand-conscious, and convenience-seeking generation.
MedCity News
AUGUST 29, 2022
Psych Hub, a mental health education startup based in Nashville, recently raised $16 million. The startup provides specialized training for mental health professionals, as well as educational content for patients. The company will use the money it raised to establish a service that matches patients with the mental health provider that is right for them.
PM360
AUGUST 29, 2022
Recently, industry and community patient advocacy pioneers came together for the Chief Patient Officer Summit. Though the title is rare, having a leader highly placed within a biopharmaceutical company solely responsible for integrating patient perspectives is no longer Pollyanna. In the context of the dueling, incongruous dynamics of patient empowerment, cost-sharing, and indisputable disparities, it’s strategic, ethical, and intuitive.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MedCity News
AUGUST 29, 2022
Renee Ryan hopes to see the vision of Cala Health’s founder – who believed that Cala Health’s wearable neurostimulation device can be one of the treatment modalities for chronic diseases like essential tremor – translated to reality.
PM360
AUGUST 29, 2022
Over-the-Counter (OTC) and Prescription (Rx) brands have invested over $3 billion in linear TV advertising during the first half of 2022, with no signs of letting up. Amidst a fragmented Convergent TV landscape that offers consumers a multitude of ways to watch their preferred programming, linear TV is still a valuable environment for pharma advertisers.
MedCity News
AUGUST 29, 2022
We must continue to push for the expansion of telehealth for Medication Assisted Treatment (MAT) more broadly and call on our federal leaders to do what is right…to change the game for good and make telehealth a permanent solution. Lives depend on it.
PM360
AUGUST 29, 2022
The adoption of Electronic Health Records (EHRs) had been a slow process until 2009 when federal incentives to healthcare professionals (HCPs) to switch from paper to EHR charts became available, and when HCPs were rewarded via higher payments for meeting meaningful use criteria. HCPs needed to show they could utilize a certified EHR in a meaningful way (i.e., make patient’s health information available online within a short period of time, facilitate the electronic exchange of health informatio
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
European Pharmaceutical Review
AUGUST 29, 2022
What are the clients’ goals in seeking out a personalised culture media solution? Oftentimes, our clients’ goals are to increase cell growth, improve protein titers and optimise product quality attributes. Biopharmaceutical manufacturers find that custom media can provide tailored solutions. What are some of the challenges manufacturers face? Discussion often exposes significant problems with lot-to-lot consistency with current media suppliers and scale-up to supply all their manufacturing sites
MedCity News
AUGUST 29, 2022
Novartis drug Scemblix is the first in a new class of drugs known as STAMP inhibitors. European Commission approval of the small molecule provides a new treatment option chronic myeloid leukemia that is resistant to earlier treatments, as well as those cases in which patients cannot tolerate the other therapies for this blood cancer.
MedReps
AUGUST 29, 2022
Networking is a crucial part of every medical sales career. Getting to know people who work in the industry you’re representing, as well as the one that you’re selling products in, is the key to your success. However, it’s very easy to make mistakes while networking, ones that can have a highly negative impact on your career. Here are some of the most common errors, as well as ways to overcome them.
MedCity News
AUGUST 29, 2022
Bicycle Health provides medication for addiction treatment. Through its telehealth platform, it also offers a team of medical experts, a customized treatment plan, same-day prescription refills for medication management, peer support groups and therapy.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
PharmaVoice
AUGUST 29, 2022
The biosimilar developer is advancing a pipeline with high growth potential, including a copycat of Humira.
PharmExec
AUGUST 29, 2022
Tue, Aug 30, 2022 11:00 AM EDT Demand for real-world evidence (RWE) is rising. But which data sources can meet the need for actionable RWE? EHR vs. registry data—which is better?
Legacy MEDSearch
AUGUST 29, 2022
CereVasc, Inc., a privately held, clinical-stage, medical device company developing novel, minimally invasive treatments for neurological diseases, announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) application to initiate a pilot trial of the eShunt ® System in patients who develop communicating hydrocephalus post aneurysmal subarachnoid hemorrhage (paSAH). . “We are excited to receive IDE approval from FDA to conduct a secon
Pharmaceutical Technology
AUGUST 29, 2022
Sanyou Biopharmaceuticals and Shanghai KangaBio have signed a licencing agreement to expedite the development and innovation of the former’s monoclonal antibody drug. The latest deal will grant KangaBio an exclusive licence for the use of the antibody to carry out research, development, production and marketing of immunotherapy products. Sanyou and KangaBio will join forces to offer new prodrug development for immunotherapy based on their expertise and industry resources.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Pharmacy Times
AUGUST 29, 2022
New research indicates that COVID-19 vaccinations did not increase the risks of preterm births or gestational issues for pregnant women, despite prior conflicting evidence.
PharmaVoice
AUGUST 29, 2022
Crystal clear communication is becoming more important for businesses working in our increasingly connected world.
Pharmacy Times
AUGUST 29, 2022
Catherine Oakar, special assistant to the President for Public Health and Disparities in the Domestic Policy Council at The White House, discusses plans to address diet-related diseases in a conference held at The White House in September 2022.
Copyright Clearance Center
AUGUST 29, 2022
The post Confidence In Research appeared first on Copyright Clearance Center.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Pharmacy Times
AUGUST 29, 2022
Although the COVID-19 pandemic may have ostensibly required global populations to stand still, this stillness shrouded what was in fact a period of extensive acceleration.
Pharmaceutical Commerce
AUGUST 29, 2022
The latest people news happenings over the past month.
Pharmacy Times
AUGUST 29, 2022
Pregnant women with epilepsy showed more symptoms of anxiety and depression than healthy pregnant or non-pregnant women, but mental health screening may help.
PharmaTech
AUGUST 29, 2022
Moderna is suing Pfizer and BioNTech for allegedly infringing on patents the company filed from 2010 to 2016.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
203 
Let's personalize your content